#LCSM Chat Topic 11/1: #LCAM and the Evolution of Lung Cancer Advocacy

November 1 marks the beginning of Lung Cancer Awareness Month (#LCAM). During our next #LCSM Chat on Twitter, we will talk about how lung cancer advocacy has evolved over the past five years since #LCSM Chat began in the summer of 2013, as well as #LCAM 2018 social media resources and planned events. (Note we’re using #LCAM, not #LCAM2018 or #LCAM18–the #LCAM2018 and #LCAM18 hashtags have been taken by the liver cancer community this October). Moderator Janet Freeman-Daily (@JFreemanDaily) will lead our discussion using the following questions: T1: In your view, how… Read More

#LCSM Chat Topic 04/05/2018: Open Mic Nite

On Thursday April 5, 2018, at 8 PM Eastern Daylight Time (5 PM Pacific Daylight Time), #LCSM Chat will hold an Open Mic Nite to talk about whatever lung cancer topics are foremost on our minds. Our moderator will be Janet Freeman-Daily (@JFreemanDaily). This would be a particularly good chat for those who are just starting with Twitter or tweet chats (please check out our tweetchat primer).  Hope you’ll join us!

#LCSM Chat Topic 3/22: Slicing the Pie–How Can Lung Cancer Patient Groups, Clinicians, and Researchers Best Work Together?

Lung cancer management has shifted from a broadly defined process to one increasingly recognized as narrow subgroups that have distinct patterns of cancer biology and optimal treatments.  The first patient group to splinter into a separate branch of management was the approximately 10% of people with EGFR mutation-positive NSCLC, and the treatment options for them continue to become deeper and more complex as we gain more active agents and struggle with enviable problems like the best sequencing and protection of the brain against metastatic spread. Other “driver mutations” such as ALK and… Read More